All News

My cancer diagnosis taught me to speak up and ask, “What do I need to know?” and “What can I be doing for myself?”

Gay and bisexual men with prostate cancer may have different needs that need to be addressed with health care providers as they go through treatment and beyond.

When all is said and done what is important to me was that we did all we could to save her. And when that failed, we did all we could to make her passing as peaceful as possible.

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

Watch Dr. William J Gradishar, Dr. Kevin Kalinsky and Kelly Thomas answer questions about hormone receptor-positive and triple-negative breast cancer treatment options during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Choosing to get a mastectomy was a difficult decision to make, but then the pathology results came back indicating a second cancer.

We recently asked our audience how they advocate for themselves and others in the oncology space. Here’s what they had to say.

After going through cancer, I better recognize my triggers for heightened anxiety.

Patients with HER2-positive breast cancer often need to undergo aggressive treatment, but ongoing research is determining if chemotherapy can be scaled back for certain patients.

After being diagnosed with breast cancer, I learned more about the disparities that Black women with the disease face.

This FDA approval of Zynyz was based on findings from a study which demonstrated that the therapy improves responses in patients with locally advanced Merkel cell carcinoma.

As a breast cancer survivor, it’s not only my duty to help the newly diagnosed, but it’s also my responsibility to heed the advice of seasoned champions.

A multiple myeloma survivor discusses how continued minimal residual disease negativity made her feel more confident in coming off of maintenance therapy.

Watch Dr. William J. Gradishar, from Northwestern University, discuss the management of hormone receptor-positive disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

The National Comprehensive Cancer Network updated their guidelines to state that Qinlock is the recommended second-line treatment for patients with Sutent-intolerant gastrointestinal stromal tumors.

An expert recommends that people who are anxious wait until the doctor’s office or clinic is open before clicking on the email that holds their test results.

Since I’ve become a patient and advocate, my social media algorithm now mostly shows cancer-related content. Here’s an open letter to said algorithm, or as I call it, “Algo.”

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

Watch Isabel Octaviano, from Miami Cancer Institute, Baptist Health South Florida, discuss the nursing perspective to clinical trials during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Pre- and post-menopausal patients with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation are eligible to participate in the next round of Fablyn’s upcoming clinical trial.

Exercise, from walking to running, allows patients to take control of their bodies at a time when things may feel out of reach during their cancer journey.

I’ve met too many people who were told that they were too young for cancer before being diagnosed.

I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving.

Watch Dr. Reshma Mahtani, from Miami Cancer Institute, Baptist Health South Florida, discuss clinical trial myths during the CURE Educated Patient® Breast Cancer Summit at MBCC.

A new method of chemotherapy administration is being explored for certain solid cancers.

While I decided to tell friends, family and even TSA agents about my cancer, others are much more private about their diagnosis, and I wonder why.

Personalized medicine means not only more powerful drugs for cancers, but also more precise mechanisms that target the specific consequence of mutations and other alterations that drive cancer cell growth, sparing normal cells.

Many well-meaning people wanted to hug me after hearing of my rectal cancer diagnosis, but I’m not a very touchy person. So, loved ones supported me in other ways.